Neuroblastoma
Year: 2018
Type: review
DOI: 10.1093/jjco/hyx176
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: neuroblastoma, pediatric solid tumors, MYCN amplification, ALK mutations, familial neuroblastoma, germline mutations, epigenetic abnormalities, risk stratification, high-risk neuroblastoma, myeloablative chemotherapy, minimal residual disease, immunotherapy, differentiation therapy, tumor microenvironment
Open Access status: closed
OpenAlex ID: W4211078399
